Cohance Lifesciences Ltd.
462.35+17.0 (+3.81%)
26 Aug, 3:30 PM
Annual Reports and Financial Documents
Cohance Lifesciences Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
Corporate Announcements and Regulatory Filings
Cohance Lifesciences Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
- Board Meeting Intimation for Considering The Unaudited Financial Results (Standalone And Consolidated) Of The Company, For The Quarter Ended 30 June 2026Cohance Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2026 ,inter alia, to consider and approve the Unaudited Financial ....
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for CSC Global Capital Markets (Singapore) Pte Ltd
- Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for CSC Global Capital Markets (Singapore) Pte Ltd
- Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on June ....
- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 17, 2026 for Jusmiral Holdings Ltd & Others
- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 17, 2026 for Jusmiral Holdings Ltd & Others
Frequently Asked Questions
Where can I download the annual report of Cohance Lifesciences Ltd.?
Annual reports of Cohance Lifesciences Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Cohance Lifesciences Ltd.?
Quarterly earnings results and presentations of Cohance Lifesciences Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Cohance Lifesciences Ltd. publish earnings call transcripts?
Earnings call transcripts of Cohance Lifesciences Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Cohance Lifesciences Ltd.?
Investor presentations and annual day presentations of Cohance Lifesciences Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Cohance Lifesciences Ltd.?
Corporate announcements and regulatory filings of Cohance Lifesciences Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Cohance Lifesciences Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Cohance Lifesciences Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Cohance Lifesciences Ltd.?
The ISIN (International Securities Identification Number) of Cohance Lifesciences Ltd. is INE03QK01018. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Cohance Lifesciences Ltd. listed?
Cohance Lifesciences Ltd. is listed on NSE and BSE. The NSE symbol is SUVENPHAR and the BSE code is -.
Where can I find the shareholding pattern of Cohance Lifesciences Ltd.?
The quarterly shareholding pattern of Cohance Lifesciences Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Cohance Lifesciences Ltd. on Sharpely?
Share price data for Cohance Lifesciences Ltd. is updated as of 26 Aug 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.